220 related articles for article (PubMed ID: 9053442)
1. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses.
Marinaro M; Boyaka PN; Finkelman FD; Kiyono H; Jackson RJ; Jirillo E; McGhee JR
J Exp Med; 1997 Feb; 185(3):415-27. PubMed ID: 9053442
[TBL] [Abstract][Full Text] [Related]
2. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.
Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):114-21. PubMed ID: 9886376
[TBL] [Abstract][Full Text] [Related]
3. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses.
Okahashi N; Yamamoto M; Vancott JL; Chatfield SN; Roberts M; Bluethmann H; Hiroi T; Kiyono H; McGhee JR
Infect Immun; 1996 May; 64(5):1516-25. PubMed ID: 8613355
[TBL] [Abstract][Full Text] [Related]
5. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
[TBL] [Abstract][Full Text] [Related]
6. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
7. The role of Th1 and Th2 cells for mucosal IgA responses.
Yamamoto M; Vancott JL; Okahashi N; Marinaro M; Kiyono H; Fujihashi K; Jackson RJ; Chatfield SN; Bluethmann H; McGhee JR
Ann N Y Acad Sci; 1996 Feb; 778():64-71. PubMed ID: 8611017
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunity: regulation by helper T cells and a novel method for detection.
Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR
J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406
[TBL] [Abstract][Full Text] [Related]
9. IL-12 is an effective adjuvant for induction of mucosal immunity.
Boyaka PN; Marinaro M; Jackson RJ; Menon S; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):122-8. PubMed ID: 9886377
[TBL] [Abstract][Full Text] [Related]
10. Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity.
Boyaka PN; Marinaro M; Jackson RJ; van Ginkel FW; Cormet-Boyaka E; Kirk KL; Kensil CR; McGhee JR
J Immunol; 2001 Feb; 166(4):2283-90. PubMed ID: 11160283
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of gut immunologic reactions: selective induction of distinct responses to Vibrio cholerae WO7 and its toxin.
Walia K; Vohra H; Singh H; Ganguly NK
Microbiol Immunol; 2000; 44(11):931-40. PubMed ID: 11145274
[TBL] [Abstract][Full Text] [Related]
12. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.
VanCott JL; Staats HF; Pascual DW; Roberts M; Chatfield SN; Yamamoto M; Coste M; Carter PB; Kiyono H; McGhee JR
J Immunol; 1996 Feb; 156(4):1504-14. PubMed ID: 8568254
[TBL] [Abstract][Full Text] [Related]
13. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
14. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 12 and innate molecules for enhanced mucosal immunity.
Boyaka PN; Lillard JW; McGhee J
Immunol Res; 1999; 20(3):207-17. PubMed ID: 10741861
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-12 alters helper T-cell subsets and antibody profiles induced by the mucosal adjuvant cholera toxin.
Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; McGhee JR
Ann N Y Acad Sci; 1996 Oct; 795():361-5. PubMed ID: 8958955
[TBL] [Abstract][Full Text] [Related]
17. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
[TBL] [Abstract][Full Text] [Related]
18. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
[TBL] [Abstract][Full Text] [Related]
19. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
Yamamoto S; Kiyono H; Yamamoto M; Imaoka K; Fujihashi K; Van Ginkel FW; Noda M; Takeda Y; McGhee JR
Proc Natl Acad Sci U S A; 1997 May; 94(10):5267-72. PubMed ID: 9144226
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.
Takahashi I; Marinaro M; Kiyono H; Jackson RJ; Nakagawa I; Fujihashi K; Hamada S; Clements JD; Bost KL; McGhee JR
J Infect Dis; 1996 Mar; 173(3):627-35. PubMed ID: 8627026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
